Abstract
Myeloproliferative neoplasms (MPN) are a group of malignant myeloid tumors caused by hematopoietic stem cell proliferation. The discovery of gene mutations has elucidated the pathogenesis of MPN and provided molecular diagnostic criteria for MPN. Recent studies have shown that there are cytokine disorders in MPN patients, and the changes in the microenvironment caused by these cytokine disorders may have great significance for the pathophysiology and pathogenesis of MPN, which may lead to corresponding clinical symptoms and different prognosis in patients. In this review, the latest research progress on the role and status of cytokines in MPN will be summarized.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.